Right ventricular cardiomyopathy is characterized by a progressive myo
cyte loss and fibro-fatty substitution of the right ventricle. The aim
of our study was to assess the diagnostic accuracy of right ventricul
ar endomyocardial biopsy. Using an imaging analyser system, histomorph
ometric parameters of myocytes, interstitium, fibrous tissue and fatty
tissue were evaluated on endomyocardial biopsy from 30 patients with
arrhythmogenic right ventricular cardiomyopathy, 29 patients with dila
ted cardiomyopathy and 30 control patients. The percent area of myocyt
es decreased from 78.10 +/- 7.34 in control to 63.39 +/- 9.22 in dilat
ed cardiomyopathy (P < 0.05) and to 47.28 +/- 15.01 in arrhythmogenic
right ventricular cardiomyopathy (P < 0.01). Fibrous tissue increased
from 8.10 +/- 3.89 in control to 21.80 +/- 9.29 in dilated cardiomyopa
thy (P < 0.05) and to 24.60 +/- 11.37 in arrhythmogenic right ventricu
lar cardiomyopathy (P < 0.05). Fatty tissue varied from 0.33 +/- 1.44
in control and 0.07 +/- 0.31 in dilated cardiomyopathy to 13.30 +/- 17
.30 in arrhythmogenic right ventricular cardiomyopathy (P < 0.05). Fat
ty tissue was a feature of arrhythmogenic right ventricular cardiomyop
athy (67% of patients vs. 6% of control and dilated cardiomyopathy pat
ients). Diagnostic values typifying arrhythmogenic right ventricular c
ardiomyopathy, obtained by excluding any overlapping between confidenc
e intervals in the three groups, were: myocytes < 44.95%; fibrous tiss
ue > 40.38%, and fatty tissue > 3.21%, with 67% sensitivity and 91.53%
specificity for at least one parameter. In conclusion, a significant
difference between arrhythmogenic right ventricular cardiomyopathy, di
lated cardiomyopathy and control exists in terms of amount of myocytes
, fibrous tissue and fatty tissue. Presence of fatty tissue and fibrou
s tissue exceeding 3.21% and 40.38%, respectively should be considered
highly suspect for arrhythmogenic fight ventricular cardiomyopathy in
right ventricular endomyocardial biopsy.